Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LXEO
PALI
Add up to 3 more stocks
LXEO
Lexeo Therapeutics, Inc. Common Stock
-1.61%
$3.35-0.06Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$263.44M
52W Range
$2.98 - $10.99
PALI
Palisade Bio, Inc.
+3.08%
$1.50+0.04Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$261.24M
52W Range
$1.32 - $2.86
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.12 | 2.15 |
| P/S Ratio | N/A | 522.47 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | -6388.2% |
| ROE | -37.1% | -26.2% |
| ROA | -34.2% | -25.1% |
| ROIC | -39.8% | -29.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 13.89 | 24.26 |
| Quick Ratio | 13.89 | 24.26 |
| Debt/Equity | 0.03 | 0.00 |
| Interest Coverage | -530.37 | -1805.60 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.